BSE filing, BSE: 543346. Summary written from the filing by ALFA Finder's alert engine.
Aashka Hospitals Ltd: key numbers
- Share price
- ₹97.95
- Market cap
- ₹229.2 Cr
- Revenue (annual)
- ₹23.01 Cr
- Net profit (annual)
- ₹3.34 Cr
- P/E (TTM)
- 68.7×Sector 52.8×
- Promoter holding
- 61.34%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aashka Hospitals Ltd
All →Koura Fine Diamond Jewelry H1 FY27 Results: Net Profit ₹3.1 Cr, Up 675.0% YoY
Koura Fine Diamond Jewelry Ltd reported revenue from operations of ₹63.8 Cr (+6.3% YoY) and net profit of ₹3.1 Cr (+675.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹3.1 Cr · +675.0% YoY
Aashka Hospitals Price Movement Clarification
Aashka Hospitals clarified that the recent significant movement in its share price is purely market-driven. The company is unaware of any specific reason for this movement.
Aashka Hospitals Annual General Meeting
Aashka Hospitals Ltd held its 14th Annual General Meeting on 24 September 2026. The meeting transacted ordinary and special business resolutions as per the notice.
Aashka Hospitals Annual Report
Aashka Hospitals has submitted its Annual Report for the financial year 2025-26, pursuant to Regulation 34 of the SEBI LODR Regulations.
Aashka Hospitals Annual General Meeting
Aashka Hospitals Ltd has issued a notice for its 14th Annual General Meeting scheduled for September 24, 2026. Shareholders will consider accounts and special resolutions.
Aashka Hospitals Board Meeting Outcome
Aashka Hospitals Ltd. board re-appointed Mr. Bipinchandra D. Shah as Chairman and Managing Director. The company also decided not to incorporate a proposed subsidiary.
Other board meeting date announcements
All →Prism Medico and Pharmacy Board Meeting Date
Prism Medico and Pharmacy will hold a board meeting on November 5, 2026 to consider unaudited standalone half-yearly financial results for the period ended September 2026. The trading window closes from October 1 until November 7, 2026.
Fredun Pharmaceuticals Board Meeting Date
Fredun Pharmaceuticals will hold a board meeting on 05 November 2026 to consider half-year results. Trading window stays closed until 48 hours after results.
Capricorn Systems Global Solutions Board Meeting Date
Capricorn Systems Global Solutions Ltd notified BSE of a board meeting on 07 November 2026 to consider unaudited financial results for the quarter and half-year ended 30 September 2026. The filing is an advance notice with no results figures attached.
Ganesh Green Bharat Board Meeting Date
Ganesh Green Bharat will hold a board meeting on 5 November 2026 to consider unaudited half-yearly results. Trading window stays closed until 10 November 2026.
Yogi Board Meeting Date
YOGI Ltd schedules a board meeting on 5 November 2026 for Q2 results and a director regularisation. Trading window closes 1 October to 7 November 2026.
Superhouse Board Meeting Date
Superhouse Limited will hold a board meeting on 14-Nov-2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from 01-Oct-2026 until 17-Nov-2026.